35% mortality rate reduction, compared with remdesivir 40%

来源: voiceofme 于 2020-08-23 15:09:56 [档案] [博客] [旧帖] [给我悄悄话] 阅读数 : (468 bytes)

本帖于 2020-08-23 15:10:27 时间, 由普通用户 voiceofme 编辑

回答: FDA紧急批准了用得过新冠的人的血浆（convalescent plasma）治疗新冠由辛迪16 于 2020-08-23 14:53:24

Remdesivir reduces mortality rate from 11.9% to 7.1% for tested cases, but not statistical significant even though it is close to. That is 40% reduction. Not sure if this 35% reduction is statistical significant or not, and if it is from controlled clinical trial or not.

But considering with the above data, I don't get what Trump said in the press conference, "it is a HISTORICAL annoucement".

您的位置：文学城 » 论坛 » 时事述评 » 35% mortality rate reduction, compared with remdesivir 40%

所有跟帖：

• What is your significant level to prove your statistical -闲舞霓裳- ♀ (720 bytes) () 08/23/2020 postreply 15:26:01

• 奇怪了，FDA头头说very effective，川普又不是FDA的，只是重复FDA的话，居然也能往Trump身上扯 -特殊地带- ♀ (0 bytes) () 08/23/2020 postreply 15:39:29

• 难道FDA说很有效，川总说没效才满意？病态啊 -特殊地带- ♀ (0 bytes) () 08/23/2020 postreply 15:40:48

• 如果川普也说有效，马上就有一帮人说没效了 -大山里的人- ♂ (0 bytes) () 08/23/2020 postreply 16:34:10

请您先登陆，再发跟帖！